| Date | Subject |
| 02/06/2012 06:01:34 PM | |
| Study Examines Association Between ART, Severity of Psychiatric Disorders in HIV+ Youth |
| 12/22/2011 02:52:19 PM | |
| Prophylactic Nevirapine to Prevent Mother-to-Child HIV Transmission Can Be Safely Extended |
| 12/21/2011 06:39:40 PM | |
| FDA Expands Use of Raltegravir to Children and Adolescents With HIV |
| 12/01/2011 05:39:32 PM | |
| CD4+ Testing as Effective as Viral Load Testing for HIV Treatment Monitoring |
| 10/21/2011 04:00:14 PM | |
| Early HIV Treatment Significantly Increases Survival in Patients Co-Infected With Tuberculosis |
| 09/28/2011 05:09:14 PM | |
| Oral Tenofovir Ineffective for Preventing HIV Transmission in Women |
| 09/21/2011 08:22:37 PM | |
| Switching to Emtricitabine/Tenofovir HIV Regimen Can Improve Lipids, Reduce Risk of Virologic Failure: Presented at ICAAC |
| 08/03/2011 05:11:42 PM | |
| US Data Show Alarming Increase in New HIV Infections Among Young, Black Gay Men |
| 07/27/2011 05:25:04 PM | |
| Study: Viral Hepatitis Rates Forecast a Liver Health Crisis |
| 07/23/2011 06:53:58 AM | |
| Analysis Shows Infant Nevirapine Prophylaxis May Prevent Breast Milk HIV Transmission: Presented at IAS |
| 07/23/2011 06:43:50 AM | |
| Preventing HIV-1 Transmission With Early Antiretroviral Therapy: Presented at IAS |
| 07/23/2011 06:20:54 AM | |
| Investigational Once-Daily Elvitegravir Appears Noninferior to Twice-Daily Raltegravir: Presented at IAS |
| 07/22/2011 06:40:18 AM | |
| Resistant HIV Observed in Young Adults First Presenting With Infection: Presented at IAS |
| 07/22/2011 06:35:15 AM | |
| Researchers Call for Further Study of Tenofovir-Containing Regimen for Initial HIV Therapy: Presented at IAS |
| 07/20/2011 05:12:57 PM | |
| Study IDs Predictors of Mortality Among Patients Initiating Antiretroviral Therapy in India: Presented at IAS |
| 06/13/2011 05:56:55 PM | |
| Children With HIV Respond Poorly to Hepatitis B Vaccine if HAART Is Interrupted: Presented at ESPID |
| 04/11/2011 06:38:13 PM | |
| Dual-Therapy Antiretroviral Therapy Maintains Viral Suppression: Presented at BHIVA |
| 04/11/2011 06:33:39 PM | |
| Concomitant Medications Should Be Monitored in Patients With HIV on Antiretroviral Therapy: Presented at BHIVA |
| 04/10/2011 04:00:32 PM | |
| Once-Daily Emtricitabine/Tenofovir/Efavirenz Tablet Maintains Viral Suppression in HIV+ Patients at 48 Weeks: Presented at BHIVA |
| 04/10/2011 02:40:30 PM | |
| Presence of Atazanavir-Related Hyperbilirubinaemia Does Not Affect HIV Clinical Outcome: Presented at BHIVA |
| 04/10/2011 01:57:34 PM | |
| No Increased Cardiovascular Risk Seen With Abacavir-Based Treatment in Patients With HIV: Presented at BHIVA |
| 04/10/2011 01:48:06 PM | |
| Continuous Tenofovir-Based HAART Controls HIV Disease Symptoms at 10 Years: Presented at BHIVA |
| 04/04/2011 06:29:44 PM | |
| AIDS Associated With an Increased Risk of Some Stomach, Oesophageal Cancers |
| 03/28/2011 11:45:09 AM | |
| Capsaicin (8%) Patch Significantly Reduces Neuropathic Pain in Patients With HIV-Associated Neuropathy: Presented at AAPM |
| 03/14/2011 08:08:56 PM | |
| Tumour Suppressor Blocks Viral Growth in Natural HIV Controllers |
| 11/22/2010 05:31:35 PM | |
| ACOG Publishes Guidelines on Gynecologic Care for Women With HIV |
| 11/18/2010 05:20:43 PM | |
| White Blood Cell Count a Useful Cardiac-Event Predictor in Patients With HIV: Presented at AHA |
| 10/25/2010 07:16:01 PM | |
| Safety Findings for TMC278, Efavirenz Are Similar Across Both Race and Gender: Presented at IDSA |
| 09/20/2010 12:47:19 PM | |
| PRO2000 Vaginal Gel Does Not Protect African Women From HIV Infection |
| 09/16/2010 12:37:49 PM | |
| Switching Antiretroviral Regimens Can Benefit Patients' Lipid Profiles: Presented at ICAAC |
| 09/16/2010 12:21:04 PM | |
| Raltegravir Pharmacokinetics Disrupted by Antacids in Healthy Patients With HIV: Presented at ICAAC |
| 09/15/2010 02:31:41 PM | |
| Vicriviroc Reduces HIV Viral Load But Falls Short in Efficacy Among Treatment-Naïve Patients: Presented at ICAAC |
| 09/15/2010 01:31:35 PM | |
| Investigative 4-Drug Combination Tablet for HIV Non-Inferior to Standard 3-Drug Combo: Presented at ICAAC |
| 09/13/2010 11:38:19 AM | |
| Investigative Tesamorelin Reduces HIV-Associated Visceral Fat in Multiple Sub-Populations: Presented at ICAAC |
| 09/07/2010 05:11:56 PM | |
| Nevirapine Switch May Benefit Some Children With HIV Who Have Achieved Viral Suppression |
| 09/01/2010 05:47:46 PM | |
| Revaccination Could Benefit Children With HIV |
| 08/12/2010 11:49:04 AM | |
| Poor Kidney Function Common Among HIV-Infected Injection Drug Users |
| 07/13/2010 05:17:41 PM | |
| Patients With Haemophilia Co-Infected With HCV/HIV Derive Liver Benefits From HAART: Presented at Haemophilia 2010 |
| 06/12/2010 05:12:28 PM | |
| Patients With HIV May Suffer Damage to Inner Retinal Leading to Loss of Visual Sensitivity: Presented at WOC |
| 04/26/2010 06:43:29 PM | |
| Switching to Darunavir/Ritonavir Reverses Severe Vitamin D Deficiency in HIV Patients: Presented at BHIVA |
| 04/24/2010 09:02:30 PM | |
| Early HAART in Pregnancy Improves Chances of Undetectable Viral Load at Delivery: Presented at BHIVA |
| 04/24/2010 05:44:09 PM | |
| Early Viral Suppression Has No Impact on Long-Term Viral Rebound Rate: Presented at BHIVA |
| 04/24/2010 02:41:41 PM | |
| Despite Toxicity, Long-Term Thymidine Use Can Benefit Patients With HIV: Presented at BHIVA |
| 04/24/2010 02:37:35 PM | |
| Three Drugs Unnecessary in HIV Patients With M184 Mutation: Presented at BHIVA |
| 03/26/2010 06:22:16 PM | |
| Daily Co-trimoxazole Prophylaxis Reduces Mortality in Severely Immunosuppressed HIV-Infected Adults Starting Treatment in Africa |
| 03/02/2010 05:42:23 PM | |
| Nevirapine Can Be Resumed 1 Year After Childbirth in Mothers With HIV |
| 02/21/2010 04:58:45 PM | |
| Older Patients With HIV at Greater Risk of Fragility Fractures: Presented at CROI |
| 02/21/2010 04:48:45 PM | |
| Increased Treatment of HIV-Positive Patients Associated With Decline in New Infections: Presented at CROI |
| 02/21/2010 04:43:10 PM | |
| Neurological Impairment Observed Early in HIV-Infection: Presented at CROI |
| 02/21/2010 04:39:06 PM | |
| Outcomes in Patients Diagnosed With H1N1 Not Affected by HIV Status: Presented at CROI |
| 02/21/2010 03:21:10 PM | |
| Newer HIV Antiretroviral Regimens Produce Few Cases of Lipoatrophy: Presented at CROI |
| 02/21/2010 03:18:39 PM | |
| Once-Daily Darunavir Noninferior to Twice-Daily Dosing in Treatment-Experienced Patients: Presented at CROI |
| 02/21/2010 03:15:34 PM | |
| Capsaicin Patch Fails to Ease HIV-Associated Polyneuropathy: Presented at CROI |
| 01/21/2010 04:15:02 PM | |
| Acyclovir Does Not Reduce Risk of HIV transmission, Study Finds |
| 01/12/2010 05:42:29 PM | |
| Switching HIV-Infected Patients to Raltegravir Improves Lipids, But With Lower Virological Control |
| 01/07/2010 07:08:11 PM | |
| Study Finds Increased Presence, Severity of Coronary Artery Plaques in HIV-Positive Men |
| 11/01/2009 04:10:24 PM | |
| Neurocognitive Issues Plague HIV-Infected Patients Taking Antiretroviral Therapy: Presented at IDSA |
| 11/01/2009 03:32:43 PM | |
| Antiretroviral-Experienced Patients Maintain HIV Suppression Through 144 Weeks: Presented at IDSA |
| 11/01/2009 01:27:17 PM | |
| No Gender Differences Seen With Atazanavir Treatment for HIV Infection: Presented at IDSA |
| 10/20/2009 05:21:23 PM | |
| Combination HIV Vaccine Regimen Demonstrates Modest Efficacy |
| 10/07/2009 06:07:19 PM | |
| CD4 Cell Count Key to Predicting Risk of Cancers in Patients With HIV |
| 09/18/2009 04:08:18 PM | |
| Nevirapine Rapidly Reduces HIV Viral Load, Shows Similar Overall Response to Atazanavir Plus Ritonavir in Combination Therapy: Presented at ICAAC |
| 09/16/2009 02:10:00 PM | |
| Metabolic Changes Favour Raltegravir Therapy in HIV-Infected Patients: Presented at ICAAC |
| 09/14/2009 12:12:24 PM | |
| Raltegravir Continues to Show Noninferiority to Efavirenz-Based HIV Therapy Through 96 Weeks: Presented at ICAAC |
| 09/14/2009 10:18:32 AM | |
| Once-Daily Lopinavir/Ritonavir Tablet Approved in EU for Treatment-Naïve HIV Patients |
| 08/31/2009 04:11:22 PM | |
| HIV Subtype D Linked to Increased Likelihood for Dementia |
| 08/26/2009 02:35:30 PM | |
| US Updates Paediatric HIV Guidelines for Prevention, Treatment of Opportunistic Infections |
| 08/17/2009 11:55:02 AM | |
| Updated HIV Guidelines Emphasise Primary Care Need of Patients |
| 08/02/2009 06:30:12 PM | |
| Raltegravir-Based Regimen an Effective Alternative to Efavirenz in Treatment-Naïve HIV Patients |
| 07/27/2009 02:38:39 PM | |
| HIV-Positive Injecting Drug Users Respond as Well as Non-Drug Injectors to First-Line Therapy: Presented at IAS |
| 07/24/2009 05:24:01 PM | |
| Study Identifies Distinct Characteristics of Patients Presenting With Late Stage HIV: Presented at IAS |
| 07/24/2009 02:36:27 PM | |
| Most Patients With HIV Respond Well to Syphilis Therapy: Presented at IAS |
| 07/23/2009 06:18:57 PM | |
| Once-Daily Darunavir/Ritonavir Monotherapy as Effective as Standard HAART: Presented at IAS |
| 07/23/2009 06:13:51 PM | |
| Simplified HIV Regimen Without Ritonavir Effective in HIV Patients With Suppressed Viral Loads: Presented at IAS |
| 07/23/2009 06:12:08 PM | |
| No Link Found Between Abacavir and Cardiovascular Disease Biomarkers: Presented at IAS |
| 07/23/2009 05:50:34 PM | |
| Abacavir Does Not Appear to Increase MI, Stroke Risk in Most HIV-Positive Patients: Presented at IAS |
| 07/23/2009 05:34:08 PM | |
| New Lab Test Gives Clues to Kidney Injury in ICU Patients, HIV-Related Kidney Disease |
| 07/23/2009 05:22:18 PM | |
| Once-Daily Lopinavir/Ritonavir as Effective as Twice Daily Dosing in Treatment-Experienced HIV Patients: Presented at IAS |
| 07/23/2009 03:10:58 PM | |
| Switching to a Nevirapine-Based Regimen Feasible in Children Previously Exposed to Single-Dose Nevirapine: Presented at IAS |
| 07/23/2009 02:58:43 PM | |
| Progression of HIV Appears to Be Slowed by Acyclovir: Presented at IAS |
| 07/23/2009 02:34:47 PM | |
| Acyclovir Fails to Prevent HIV Transmission in Discordant Couples: Presented at IAS |
| 07/23/2009 01:33:13 PM | |
| Non-Active Antiretrovirals Should Not Be Part of Effective Salvage Regimens: Presented at IAS |
| 07/23/2009 11:43:04 AM | |
| New Antiretrovirals Overpower Resistant HIV Virus Allowing Patients to Achieve Undetectable Viral Loads: Presented at IAS |
| 07/23/2009 10:25:38 AM | |
| Boosted Atazanavir Effective in Lowering Viral Load in Patients With Advanced HIV: Presented at IAS |
| 07/22/2009 06:21:36 PM | |
| Once-Daily Lopinavir/Ritonavir Tablets Show Similar, Durable Efficacy as Twice-Daily Dosing: Presented at IAS |
| 07/21/2009 04:04:31 PM | |
| Most Patients With NNRTI Resistance Maintain Susceptibility to Etravirine: Presented at IAS |
| 07/21/2009 03:48:01 PM | |
| Use of Statins Does Not Interfere With Efficacy of Maraviroc: Presented at IAS |
| 07/21/2009 03:10:50 PM | |
| Treatment of HIV With Darunavir Appears as Successful in Treatment-Experienced Men as in Women: Presented at IAS |
| 07/21/2009 03:09:22 PM | |
| HIV Suppression Maintained Despite 2-Day Breaks in Drug Therapy: Presented at IAS |
| 07/21/2009 02:35:30 PM | |
| Maraviroc Has Durable Treatment Effect at 96 Weeks in Treatment-Naïve HIV Patients: Presented at IAS |
| 07/21/2009 12:57:00 PM | |
| Females, African American Have Reduced Virologic Responses to Treatment: Presented at IAS |
| 07/21/2009 12:39:56 PM | |
| Etravirine Continues to Be Well Tolerated at 96 Weeks in Treatment-Experienced HIV Patients: Presented at IAS |
| 07/20/2009 06:21:05 PM | |
| Raltegravir Maintains Efficacy Versus Efavirenz After 144 Weeks: Presented at IAS |
| 07/20/2009 05:47:06 PM | |
| Nevirapine Equally Effective, Improves Lipids Compared With Atazanavir in HIV: Presented at IAS |
| 07/20/2009 05:32:33 PM | |
| Etravirine Offers Durable Virologic Efficacy in Patients Resistant to NNRTIs and PIs: Presented at IAS |
| 05/20/2009 03:55:24 PM | |
| Children With HIV Gain More Weight With Atypical Antipsychotics: Presented at APA |
| 05/04/2009 04:03:38 PM | |
| Better Anal Cytology Screening Practices Needed for HIV-Infected Youth: Presented at PAS |
| 05/01/2009 12:33:58 PM | |
| Human Papillomavirus Associated With Higher Risk of New HIV Infection |
| 05/01/2009 11:14:50 AM | |
| Pregabalin Fares Little Better Than Placebo in Treating HIV-Associated Neuropathy: Presented at AAN |
| 04/27/2009 05:00:21 PM | |
| Vaccinations in Children With HIV Possible if HAART is Initiated Early |
| 04/27/2009 02:21:37 PM | |
